Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Randomized Controlled Trial of Hydroxychloroquine and Azithromycin for COVID-19 Infection on Hospitalized, Noncritical Patients

NCT04322123 is registered in ClinicalTrials.gov with Hospital do Coracao as lead sponsor.

NCT NCT04322123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04322123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Randomized Controlled Trial of Hydroxychloroquine and Azithromycin for COVID-19 Infection on Hospitalized, Noncritical Patients
Lead sponsor
Hospital do Coracao
Phase
Phase 3
Overall status
Completed
Start date
April 1, 2020
Completion date
June 2, 2020
Enrollment
667 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infections